Literature DB >> 33672005

Relationships between Viral Load and the Clinical Course of COVID-19.

Hiroyuki Tsukagoshi1, Daisuke Shinoda1, Mariko Saito1, Kaori Okayama2, Mitsuru Sada2,3, Hirokazu Kimura2, Nobuhiro Saruki1.   

Abstract

To predict the clinical outcome of coronavirus disease-2019 (COVID-19), we examined relationships among epidemiological data, viral load, and disease severity. We examined viral loads of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in fatal (15 cases), symptomatic/survived (133 cases), and asymptomatic cases (138 cases) using reverse transcription quantitative real-time PCR (RT-qPCR). We examined 5768 nasopharyngeal swabs (NPS) and attempted to detect the SARS-CoV-2 genome using RT-qPCR. Among them, the viral genome was detected using the method for the 370 NPS samples with a positive rate of 6.4%. A comparison of each age showed that the fatal case was higher than the survived case and asymptomatic patients. Survived cases were older than asymptomatic patients. Notably, the viral load in the fatal cases was significantly higher than in symptomatic or asymptomatic cases (p < 0.05). These results suggested that a high viral load of the SARS-CoV-2 in elderly patients at an early stage of the disease results in a poor outcome. We should, therefore, intervene early to prevent a severe stage of the disease in such cases.

Entities:  

Keywords:  clinical course; coronavirus disease-2019 (COVID-19); viral load

Year:  2021        PMID: 33672005     DOI: 10.3390/v13020304

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  15 in total

1.  SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatment.

Authors:  Tobias Lahmer; Johanna Erber; Roland M Schmid; Jochen Schneider; Christoph D Spinner; Peter Luppa; Fritz Sörgel; Martina Kinzig; Sebastian Rasch
Journal:  Multidiscip Respir Med       Date:  2022-05-10

2.  Comparative Analysis of Age, Sex, and Viral Load in Outpatients during the Four Waves of SARS-CoV-2 in A Mexican Medium-Sized City.

Authors:  Carlos Eduardo Covantes-Rosales; Victor Wagner Barajas-Carrillo; Daniel Alberto Girón-Pérez; Gladys Alejandra Toledo-Ibarra; Karina Janice Guadalupe Díaz-Reséndiz; Migdalia Sarahy Navidad-Murrieta; Guadalupe Herminia Ventura-Ramón; Mirtha Elena Pulido-Muñoz; Ulises Mercado-Salgado; Ansonny Jhovanny Ojeda-Durán; Aimée Argüero-Fonseca; Manuel Iván Girón-Pérez
Journal:  Int J Environ Res Public Health       Date:  2022-05-08       Impact factor: 4.614

3.  PK/PD modeling links accelerated resolution of COVID-19-related clinical symptoms to SARS-CoV-2 viral load reduction in patients following treatment with Bamlanivimab alone or Bamlanivimab and Etesevimab together.

Authors:  C Steven Ernest; Jenny Y Chien; Dipak R Patel; Emmanuel Chigutsa
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-04-05

4.  Perspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection.

Authors:  Rohan Ameratunga; See-Tarn Woon; Richard Steele; Russell Snell; Natalie Medlicott; Emily Mears; Euphemia Leung; Klaus Lehnert; Anthony Jordan; Shyamal Das; William Abbott; Hilary Longhurst; Miguel E Quiñones-Mateu
Journal:  Expert Rev Clin Immunol       Date:  2021-05-14       Impact factor: 4.473

Review 5.  Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations.

Authors:  Fatemeh Farshadpour; Reza Taherkhani
Journal:  Med Princ Pract       Date:  2021-04-21       Impact factor: 1.927

Review 6.  Mechanisms contributing to adverse outcomes of COVID-19 in obesity.

Authors:  Manu Sudhakar; Sofi Beaula Winfred; Gowri Meiyazhagan; Deepa Parvathy Venkatachalam
Journal:  Mol Cell Biochem       Date:  2022-01-27       Impact factor: 3.842

7.  The presentation, course and outcome of COVID-19 infection in people with Prader-Willi syndrome: unexpected findings from an international survey.

Authors:  J E Whittington; A J Holland; D J Driscoll; N Hodebeck-Stuntebeck; A Hoctor
Journal:  Orphanet J Rare Dis       Date:  2022-02-21       Impact factor: 4.123

8.  Phosphopeptide enrichment using Phos-tag technology reveals functional phosphorylation of the nucleocapsid protein of SARS-CoV-2.

Authors:  Yoko Ino; Mayuko Nishi; Yutaro Yamaoka; Kei Miyakawa; Sundararaj Stanleyraj Jeremiah; Makoto Osada; Yayoi Kimura; Akihide Ryo
Journal:  J Proteomics       Date:  2022-01-29       Impact factor: 4.044

Review 9.  The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?

Authors:  Rosemary J Boyton; Daniel M Altmann
Journal:  Nat Rev Immunol       Date:  2021-10-19       Impact factor: 108.555

10.  [Valproic Acid Could Help in the Fight Against COVID-19: a case-control study].

Authors:  Oscar Moreno-Pérez; Esperanza Merino; Jose Manuel Ramos; Juan Carlos Rodríguez; Carmina Diaz; Patricio Mas; Sergio Reus; Rosario Sánchez-Martínez; Vicente Boix; Pablo Chico-Sánchez; José Sánchez-Payá; Joaquín Portilla
Journal:  Neurologia       Date:  2022-02-14       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.